Prostate cancer drug ‘as important as Herceptin’

A new drug for advanced prostate cancer has been described as being as important for treatment of the disease as Herceptin was for breast cancer, after a trial showed it gave men five extra months of life.

Researchers find more clues to causes of breast cancer

Publishing in the current issue of The Journal of Biological Chemistry , researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of “Akt” activation and suggest a component of that activation mechanism inhibitor of nuclear factor kappa-B kinase subunit epsilon could be targeted as a therapeutic intervention for treating cancer.